scholarly article | Q13442814 |
P50 | author | Fernando Macian | Q30419998 |
Thomas J Quinn | Q45310205 | ||
Ari Partanen | Q45909988 | ||
Sanmay Bandyopadhyay | Q96196836 | ||
Indranil Basu | Q96196837 | ||
P2093 | author name string | Lisa Scandiuzzi | |
Wolfgang A Tomé | |||
Chandan Guha | |||
P2860 | cites work | The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population | Q24651013 |
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma | Q24679736 | ||
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion | Q28131654 | ||
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 | ||
Enhancement of antitumor immunity by CTLA-4 blockade | Q28275730 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological response | Q30459141 | ||
Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic Cancer | Q30478607 | ||
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen | Q40333817 | ||
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance | Q40351779 | ||
Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity | Q40702024 | ||
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. | Q40773099 | ||
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor | Q41429389 | ||
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients | Q41672999 | ||
The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells | Q42218721 | ||
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway | Q44539124 | ||
A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions | Q44903259 | ||
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 | ||
High-intensity focused ultrasound in the treatment of solid tumours | Q50250147 | ||
The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells. | Q51987808 | ||
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. | Q52936850 | ||
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70 | Q72432600 | ||
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells | Q73482874 | ||
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma | Q73850975 | ||
Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo | Q73932751 | ||
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression | Q74330354 | ||
Minimal recruitment and activation of dendritic cells within renal cell carcinoma | Q74418862 | ||
Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens | Q75207773 | ||
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses | Q77715977 | ||
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. | Q30501320 | ||
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model | Q30502120 | ||
Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance | Q30504684 | ||
Overcoming immune tolerance to cancer by heat shock protein vaccines | Q33337943 | ||
Immunogenic and tolerogenic cell death | Q33639097 | ||
Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses | Q34115645 | ||
Transcriptional mechanisms underlying lymphocyte tolerance. | Q34135663 | ||
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy | Q34575119 | ||
Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance | Q34967371 | ||
A mouse tumor-specific transplantation antigen is a heat shock-related protein | Q35603985 | ||
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience | Q35670885 | ||
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression | Q35798927 | ||
CD91-dependent programming of T-helper cell responses following heat shock protein immunization | Q35973873 | ||
Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy | Q36041455 | ||
NFAT1 supports tumor-induced anergy of CD4(+) T cells | Q36243594 | ||
Heat shock protein 70-associated peptides elicit specific cancer immunity | Q36362368 | ||
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity | Q36367825 | ||
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. | Q36371632 | ||
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp | Q36375152 | ||
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells | Q36399686 | ||
Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo | Q36409007 | ||
CD40 ligation reverses T cell tolerance in acute myeloid leukemia | Q36793408 | ||
Indoleamine 2,3-dioxygenase and tumor-induced tolerance | Q36809762 | ||
Altered macrophage differentiation and immune dysfunction in tumor development | Q36809767 | ||
Host antitumour immune responses to HIFU ablation | Q36853082 | ||
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic | Q36931431 | ||
IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes | Q37153986 | ||
Immune therapy for cancer | Q37324793 | ||
Costimulatory and coinhibitory receptors in anti-tumor immunity | Q37474920 | ||
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment | Q38098365 | ||
Induction and stability of the anergic phenotype in T cells | Q38161200 | ||
Egr-2 and Egr-3 are negative regulators of T cell activation. | Q38327900 | ||
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions | Q38784095 | ||
Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. | Q40005411 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | evasion of host immune response | Q1660157 |
focused ultrasound | Q50333304 | ||
P304 | page(s) | 1964-1976 | |
P577 | publication date | 2016-01-11 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. | |
P478 | volume | 196 |
Q42973443 | Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities |
Q64102482 | Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors |
Q90169619 | Focused ultrasound activates voltage-gated calcium channels through depolarizing TRPC1 sodium currents in kidney and skeletal muscle |
Q42690545 | Immuno-thermal ablations - boosting the anticancer immune response |
Q50324081 | Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults |
Q49571153 | Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop |
Q90999148 | Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines |
Q92463724 | Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities |
Q90608556 | Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity |
Q99419129 | Opto-acoustic synergistic irradiation for vaporization of natural melanin-cored nanodroplets at safe energy levels and efficient sono-chemo-photothermal cancer therapy |
Q47933732 | Phospholipid Capped Mesoporous Nanoparticles for Targeted High Intensity Focused Ultrasound Ablation. |
Q37714274 | Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy |
Q90146977 | The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models |
Q47142549 | The use of 5-fluorouracil-loaded nanobubbles combined with low-frequency ultrasound to treat hepatocellular carcinoma in nude mice |
Q89468280 | Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo |
Q41548373 | Volumetric Optoacoustic Temperature Mapping in Photothermal Therapy. |
Search more.